Bioventus BVS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $34.54M+26.6% | $27.27M+192% | $9.35M+1,967% | -$501K+98.9% | -$43.99M+6.5% | ||
| $46.35M-1.4% | $47.01M-1.5% | $47.72M-1.8% | $48.59M-2.1% | $49.64M+0.2% | ||
| $13.52M+6.7% | $12.67M+12.7% | $11.25M+6.5% | $10.56M-16.8% | $12.7M-4.3% | ||
| $102.94M+37.9% | $74.67M+33.3% | $56.03M+54.6% | $36.25M+42.3% | $25.47M-34.3% | ||
| $2.31M-9.8% | $2.56M+0.2% | $2.56M+19.0% | $2.15M+39.3% | $1.54M+53.2% | ||
| -$3M+7.8% | -$3.25M-115% | $21.44M-1.9% | $21.85M-5.6% | $23.14M+0.8% | ||
| $40M-11.1% | $45M+28.6% | $35M+40.0% | $25M+25.0% | $20M+33.3% | ||
| -$86.23M-38.8% | -$62.14M+18.8% | -$76.55M-35.3% | -$56.57M-13.7% | -$49.75M+9.4% | ||
| $13.04M+35.1% | $9.66M— | —— | —— | —— | ||
| $100.63M+39.5% | $72.11M+34.9% | $53.47M+56.8% | $34.1M+42.5% | $23.93M-36.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bioventus generate?
- Bioventus (BVS) generated $102.9M in operating cash flow over the trailing twelve months.
- What is Bioventus's free cash flow?
- After $2.3M of capital expenditures, Bioventus's free cash flow was $100.6M over the trailing twelve months, up 320.5% year over year.
- Where does Bioventus's cash flow data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
